NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 272 filers reported holding NEOGENOMICS INC in Q1 2020. The put-call ratio across all filers is 1.09 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $60,571,215 | -23.5% | 4,924,489 | -0.0% | 0.00% | -25.0% |
Q2 2023 | $79,167,119 | -6.9% | 4,926,392 | +0.8% | 0.00% | -20.0% |
Q1 2023 | $85,069,096 | -1.0% | 4,886,170 | -47.5% | 0.01% | +66.7% |
Q4 2022 | $85,930,780 | +136.7% | 9,299,868 | +120.5% | 0.00% | +50.0% |
Q3 2022 | $36,310,000 | +8.7% | 4,217,160 | +2.8% | 0.00% | 0.0% |
Q2 2022 | $33,418,000 | -30.5% | 4,100,358 | +3.6% | 0.00% | 0.0% |
Q1 2022 | $48,104,000 | -63.0% | 3,959,163 | +4.0% | 0.00% | -66.7% |
Q4 2021 | $129,953,000 | -24.8% | 3,808,697 | +6.4% | 0.01% | -33.3% |
Q3 2021 | $172,735,000 | +9.6% | 3,580,742 | +2.6% | 0.01% | +12.5% |
Q2 2021 | $157,619,000 | -0.9% | 3,489,471 | +5.8% | 0.01% | -11.1% |
Q1 2021 | $159,129,000 | -6.3% | 3,299,376 | +4.5% | 0.01% | -10.0% |
Q4 2020 | $169,913,000 | +46.8% | 3,155,896 | +0.6% | 0.01% | +25.0% |
Q3 2020 | $115,724,000 | +16.3% | 3,137,014 | -2.3% | 0.01% | +14.3% |
Q2 2020 | $99,498,000 | +19.8% | 3,211,693 | +6.8% | 0.01% | 0.0% |
Q1 2020 | $83,040,000 | +2.5% | 3,007,606 | +8.5% | 0.01% | +16.7% |
Q4 2019 | $81,050,000 | +56.9% | 2,770,947 | +2.6% | 0.01% | +50.0% |
Q3 2019 | $51,652,000 | -8.6% | 2,701,490 | +4.9% | 0.00% | 0.0% |
Q2 2019 | $56,490,000 | +17.6% | 2,574,740 | +9.7% | 0.00% | 0.0% |
Q1 2019 | $48,019,000 | +205.4% | 2,346,975 | +88.2% | 0.00% | +300.0% |
Q4 2018 | $15,723,000 | -14.1% | 1,246,841 | +4.6% | 0.00% | 0.0% |
Q3 2018 | $18,300,000 | +27.5% | 1,192,212 | +8.9% | 0.00% | 0.0% |
Q2 2018 | $14,357,000 | +60.4% | 1,095,246 | -0.1% | 0.00% | 0.0% |
Q1 2018 | $8,949,000 | -7.1% | 1,096,660 | +0.9% | 0.00% | 0.0% |
Q4 2017 | $9,633,000 | -16.3% | 1,087,319 | +5.2% | 0.00% | 0.0% |
Q3 2017 | $11,503,000 | +28.5% | 1,033,477 | +3.4% | 0.00% | 0.0% |
Q2 2017 | $8,953,000 | +22.9% | 999,012 | +8.1% | 0.00% | 0.0% |
Q1 2017 | $7,285,000 | -7.1% | 924,261 | +1.0% | 0.00% | 0.0% |
Q4 2016 | $7,842,000 | +8.6% | 915,073 | +4.2% | 0.00% | 0.0% |
Q3 2016 | $7,222,000 | +4.7% | 878,533 | +2.4% | 0.00% | 0.0% |
Q2 2016 | $6,899,000 | +31.6% | 858,002 | +10.3% | 0.00% | 0.0% |
Q1 2016 | $5,241,000 | -13.5% | 777,559 | +0.9% | 0.00% | 0.0% |
Q4 2015 | $6,061,000 | +64.6% | 770,293 | +19.8% | 0.00% | – |
Q3 2015 | $3,683,000 | +56.7% | 642,936 | +47.9% | 0.00% | – |
Q2 2015 | $2,350,000 | +2298.0% | 434,758 | +1970.3% | 0.00% | – |
Q1 2015 | $98,000 | +11.4% | 21,000 | 0.0% | 0.00% | – |
Q4 2014 | $88,000 | -27.3% | 21,000 | -9.9% | 0.00% | – |
Q3 2014 | $121,000 | +68.1% | 23,300 | +7.4% | 0.00% | – |
Q2 2014 | $72,000 | -94.6% | 21,700 | -94.3% | 0.00% | – |
Q1 2014 | $1,330,000 | +19.7% | 383,323 | +20.6% | 0.00% | – |
Q4 2013 | $1,111,000 | +64.3% | 317,838 | +41.2% | 0.00% | – |
Q3 2013 | $676,000 | +65.7% | 225,081 | +119.6% | 0.00% | – |
Q2 2013 | $408,000 | – | 102,500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kopp Family Office, LLC | 2,023,355 | $91,395,000 | 37.83% |
Blue Water Life Science Advisors, LP | 702,222 | $31,719,000 | 11.94% |
Burrage Capital Management LLC | 147,921 | $6,682,000 | 6.70% |
PERKINS CAPITAL MANAGEMENT INC | 158,300 | $7,150,000 | 4.06% |
First Light Asset Management, LLC | 1,148,945 | $51,898,000 | 3.11% |
Soleus Capital Management, L.P. | 352,007 | $15,900,000 | 2.44% |
Ranger Investment Management | 832,286 | $37,594,000 | 1.96% |
Avidity Partners Management LP | 1,367,000 | $61,747,000 | 1.67% |
Bullseye Asset Management LLC | 108,672 | $4,909,000 | 1.65% |
Tygh Capital Management, Inc. | 255,541 | $11,543,000 | 1.57% |